The identification of a STIM2 splice variant antagonizing STIM function resets the stage for analysis of contradictory results regarding the physiological role of STIM2 (that is, in cancer and autoimmunity14) as all studies involving downregulation or knockout would affect both variants, thus dampening a ‘true' STIM2.2-mediated effect. This evidence concerns the gene STIM2 and cancer.